Yulia A Nevzorova
Overview
Explore the profile of Yulia A Nevzorova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
889
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lamas-Paz A, Hionides-Gutierrez A, Guo F, Jorquera G, Moran-Blanco L, Benede-Ubieto R, et al.
JHEP Rep
. 2024 Dec;
7(1):101230.
PMID: 39659733
Background & Aims: Expression of P21, encoded by the gene, has been associated with fibrosis progression in steatotic liver disease (SLD); however, the underlying mechanisms remain unknown. In the present...
2.
Nevzorova Y, Cubero F
Med
. 2024 May;
5(5):377-379.
PMID: 38733969
The study by Hirschfield et al. demonstrated safety profile and clinically significant effectiveness of the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar in patients with primary biliary cholangitis, highlighting its...
3.
Lamas-Paz A, Mesquita M, Garcia-Lacarte M, Estevez-Vazquez O, Benede-Ubieto R, Gutierrez A, et al.
Front Nutr
. 2024 May;
11:1393014.
PMID: 38699545
Background: Alcohol misuse, binge drinking pattern, and gender-specific effects in the middle-aged population has been clearly underestimated. In the present study, we focused on understanding gender-specific effects of alcohol exposure...
4.
Benede-Ubieto R, Cubero F, Nevzorova Y
Gut Microbes
. 2024 Mar;
16(1):2331460.
PMID: 38512763
Obesity, insulin resistance (IR), and the gut microbiome intricately interplay in Metabolic-associated Steatotic Liver Disease (MASLD), previously known as Non-Alcoholic Fatty Liver Disease (NAFLD), a growing health concern. The complex...
5.
Rodriguez-Agudo R, Gonzalez-Recio I, Serrano-Macia M, Bravo M, Petrov P, Blaya D, et al.
JHEP Rep
. 2024 Jan;
6(1):100918.
PMID: 38192540
Background & Aims: Current therapies for the treatment of alcohol-related liver disease (ALD) have proven largely ineffective. Patients relapse and the disease progresses even after liver transplantation. Altered epigenetic mechanisms...
6.
Nevzorova Y, Cubero F
Front Cell Dev Biol
. 2023 Dec;
11:1293218.
PMID: 38116204
The moonlighting protein c-Myc is a master regulator of multiple biological processes including cell proliferation, differentiation, angiogenesis, apoptosis and metabolism. It is constitutively and aberrantly expressed in more than 70%...
7.
Otto J, Verwaayen A, Penners C, Hundertmark J, Lin C, Kallen C, et al.
Cell Death Dis
. 2023 Aug;
14(8):549.
PMID: 37620309
Hepatocellular carcinoma (HCC) is one of the most severe malignancies with increasing incidence and limited treatment options. Typically, HCC develops during a multistep process involving chronic liver inflammation and liver...
8.
Zheng K, Hao F, Medrano-Garcia S, Chen C, Guo F, Moran-Blanco L, et al.
Cell Death Dis
. 2023 Aug;
14(8):514.
PMID: 37563155
Progressive hepatic damage and fibrosis are major features of chronic liver diseases of different etiology, yet the underlying molecular mechanisms remain to be fully defined. N-RAS, a member of the...
9.
Nevzorova Y, Weiskirchen R, Liedtke C
Methods Mol Biol
. 2023 May;
2669:177-191.
PMID: 37247060
Liver fibrosis is a severe health problem worldwide with increasing incidence. However, specific drugs for treatment of hepatic fibrosis are currently not available. Accordingly, there is a strong need to...
10.
Aguilar-Bravo B, Arino S, Blaya D, Pose E, Martinez Garcia de la Torre R, Latasa M, et al.
J Hepatol
. 2023 Apr;
79(3):728-740.
PMID: 37088308
Background & Aims: Loss of hepatocyte identity is associated with impaired liver function in alcohol-related hepatitis (AH). In this context, hepatocyte dedifferentiation gives rise to cells with a hepatobiliary (HB)...